We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

107 hedge funds and large institutions have $1.09B invested in Theravance Biopharma in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $2.11M

15% more capital invested

Capital invested by funds: $946M → $1.09B (+$147M)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more funds holding

Funds holding: 107 → 107 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.12% less ownership

Funds ownership: 83.21% → 82.09% (-1.1%)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

Holders
107
Holders Change
–
Holders Change %
0%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
30
Reduced
41
Closed
13
Calls
$2.72M
Puts
$2.11M
Net Calls
+$610K
Net Calls Change
+$542K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$38M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.58M
3
BlackRock
BlackRock
New York
+$2.72M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$2.11M
5
State Street
State Street
Massachusetts
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$14.7M
2
Morgan Stanley
Morgan Stanley
New York
-$8.19M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.77M
4
Ameriprise
Ameriprise
Minnesota
-$6.27M
5
Norges Bank
Norges Bank
Norway
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$3.58M +$2.11M +111,165 +173%
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$3.47M -$2M -105,000 -38%
Morgan Stanley
28
Morgan Stanley
New York
$3.24M -$8.19M -431,110 -73%
Millennium Management
29
Millennium Management
New York
$2.43M +$1.8M +94,617 +390%
HWAM
30
Hennion & Walsh Asset Management
New Jersey
$2.09M +$1.95M +102,548 New
Swiss National Bank
31
Swiss National Bank
Switzerland
$2.09M +$43.7K +2,300 +2%
Bank of America
32
Bank of America
North Carolina
$2.09M +$391K +20,579 +25%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.91M -$162K -8,509 -8%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$1.78M -$306K -16,106 -16%
MOACM
35
Mutual of America Capital Management
New York
$1.69M -$87.1K -4,585 -5%
Macquarie Group
36
Macquarie Group
Australia
$1.66M +$217K +11,417 +16%
AllianceBernstein
37
AllianceBernstein
Tennessee
$1.44M -$114K -6,000 -8%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.44M -$4.03K -212 -0.3%
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$1.36M – – –
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$1.34M – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.26M -$74.4K -3,917 -6%
UBS AM
42
UBS AM
Illinois
$1.24M – – –
RA
43
Royce & Associates
New York
$1.2M – – –
NSEDCP
44
NJ State Employees Deferred Compensation Plan
New Jersey
$1.19M +$380K +20,000 +52%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$1.14M +$398K +20,954 +60%
Barclays
46
Barclays
United Kingdom
$1.05M +$479K +25,216 +97%
CM
47
CM Management
Florida
$1.02M +$950K +50,000 New
CS
48
Credit Suisse
Switzerland
$996K -$260K -13,685 -22%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$845K – – –
DCM
50
DAFNA Capital Management
California
$840K +$782K +41,165 New
1
2
3 4 5

TBPH Hedge Fund Activity: Q1 2021 in Review

107 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q1 2021, worth a combined $1.09B — up 15% from $946M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TBPH positions and 13 closed out — a net gain of 1 holder — while 30 added to existing stakes and 41 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $38M. The largest seller was Great Point Partners, exiting entirely with an estimated $14.7M sold.

  • 107 institutional investors held Theravance Biopharma (TBPH) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $1.09B of Theravance Biopharma stock for Q1 2021, up 15% quarter-over-quarter.
  • 14 funds opened new Theravance Biopharma positions in Q1 2021 and 13 closed out, a net change of +1 holder.
  • The largest Theravance Biopharma buyer in Q1 2021 was Wellington Management Group, an estimated $38M added.
  • The largest Theravance Biopharma seller in Q1 2021 was Great Point Partners, an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2021.